Pui CH, Mullighan CG, Evans WE, Relling MV. Pediatric acute lymphoblastic leukemia: where are we going and how do we get there?[J]. Blood, 2012, 120(6): 1165-1174.
[2]
Gorschluter M, Mey U, Strehl J, Ziske C, Schepke M, Ingo GH, et al. Neutropenic enterocolitis in adults: systematic analysis of evidence quality[J]. Eur J Haematol, 2005, 75(1): 1-13.
Aksoy DY, Tanriover MD, Uzun O, Zarakolu P, Ercis S. Diarrhea in neutropenic patients: a prospective cohort study with emphasis on neutropenic enterocolitis[J]. Ann Oncol, 2007, 18(1): 183-189.
[5]
Gomez L, Martino R, Rolston KV. Neutropenic enterocolitis: spectrum of the disease and comparison of definite and possible cases[J]. Clin Infec Dis, 1998, 27(4): 695-699.
[6]
Gorschl JB Meddings. Intestinal mucosal dysfunction and infection during remission-induction therapy for acute myeloid leukaemia[J]. Eur J Haematol, 2005, 75(7): 1-13.
[7]
McCarville MB, Adelman CS, Li C, Xiong X, Furman WL, Razzouk BI, et al. Typhlitis in childhood cancer[J]. Cancer, 2005, 104(2): 380-387.
[8]
Li K, Zheng S, Dong K, Gao Y, Wang H, Liu G, et al. Diagnosis and outcome of neutropenic enterocolitis: experience in a single tertiary pediatric surgical center in China[J]. Pediatr Surg Int, 2011, 27(11):1191-1195.
Rizzatti M, Brandalise SR, de Azevedo AC, Pinheiro VR, Aguiar Sdos S. Neutropenic enterocolitis in children and young adults with cancer: prognostic value of clinical and image findings[J]. Pediatr Hematol Oncol, 2010, 27(6): 462-470.
[11]
Sloas MM, Flynn PM, Kaste SC, Patrick CC. Typhlitis in children with cancer: a 30-year experience[J]. Clin Infec Dis, 1993, 17(3): 484-490.
[12]
Hughes WT, Armstrong D, Bodey GP, Bow EJ, Brown AE, Calandra T, et al. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer[J]. Clin Infec Dis, 2002, 34(6): 730-751.
[13]
Nesher L, Rolston KVI. Neutropenic enterocolitis, a growing concern in the era of widespread use of aggressive chemo-therapy[J]. Clin Infec Dis, 2013, 56(5): 711-717.
